CD19 Universal CAR-Gamma Delta T is under clinical development by Guangzhou Bio-gene Technology and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase II drugs for ...
Some results have been hidden because they may be inaccessible to you